{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:16Z","timestamp":1792728256806,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["55877037"],"award-info":[{"award-number":["55877037"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["2021QD004"],"award-info":[{"award-number":["2021QD004"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijantimicag.2024.107356","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:00:51Z","timestamp":1728482451000},"page":"107356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant klebsiella pneumoniae with ceftazidime\u2013avibactam\u2013based regimens: a case report"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8021-4154","authenticated-orcid":false,"given":"Yinru","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-4050","authenticated-orcid":false,"given":"Wanzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4767-6959","authenticated-orcid":false,"given":"Nanyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107356_bib0001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3171\/2016.10.JNS16379","article-title":"Development of a prediction rule for diagnosing postoperative meningitis: a cross-sectional study","volume":"128","author":"Hern\u00e1ndez","year":"2018","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.ijantimicag.2024.107356_bib0002","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3171\/2013.6.JNS122126","article-title":"Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and\/or ventriculitis in a serious clinical state","volume":"119","author":"Reme\u0161","year":"2013","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107356_bib0003","first-page":"2","article-title":"[Chinese Expert Consensus on the Diagnosis and Treatment of Central Nervous System Infections in Neurosurgery (2021 edition)]","volume":"37","author":"Wang","year":"2021","journal-title":"Chin J Neurosurg"},{"issue":"6","key":"10.1016\/j.ijantimicag.2024.107356_bib0004","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107356_bib0005","series-title":"the Forty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Pharmacokinetics of the new \u03b2-lactamase inhibitor NXL104 in an experimental rabbit meningitis model: restoration of the bacteriological efficacy of ceftazidime (CAZ) against a class C producing K pneumoniae","author":"Cottagnoud","year":"2007"},{"issue":"4","key":"10.1016\/j.ijantimicag.2024.107356_bib0006","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijantimicag.2018.11.015","article-title":"Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam","volume":"53","author":"De la Calle","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.ijantimicag.2024.107356_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106777","article-title":"Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae","volume":"61","author":"Zhao","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107356_bib0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/IDR.S191892","article-title":"High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China","volume":"12","author":"Xu","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"9854","key":"10.1016\/j.ijantimicag.2024.107356_bib0009","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(12)61186-6","article-title":"Advances in treatment of bacterial meningitis","volume":"380","author":"van de Beek","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijantimicag.2024.107356_bib0010","first-page":"e0446","article-title":"Setting the beta-lactam therapeutic range for critically ill patients: is there a floor or even a ceiling?","volume":"3","author":"Barreto","year":"2021","journal-title":"Crit Care Explor"},{"issue":"8","key":"10.1016\/j.ijantimicag.2024.107356_bib0011","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107356_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:44:11Z","timestamp":1778766251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924002723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0924857924002723"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107356","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant klebsiella pneumoniae with ceftazidime\u2013avibactam\u2013based regimens: a case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107356"}}